Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.6926
+0.0174 (2.58%)
At close: Apr 7, 2026, 4:00 PM EDT
0.6705
-0.0221 (-3.19%)
After-hours: Apr 7, 2026, 7:23 PM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $16.23 million as of April 7, 2026. Its market cap has decreased by -76.65% in one year.
Market Cap
16.23M
Enterprise Value
-7.89M
1-Year Change
-76.65%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $16.23M, a decrease of -92.23%. That is a compound annual growth rate of -44.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 16.23M | -53.52% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 19.20M |
| Citius Pharmaceuticals | 19.11M |
| Tevogen Bio Holdings | 18.57M |
| Allarity Therapeutics | 18.35M |
| Lantern Pharma | 18.16M |
| Cue Biopharma | 17.57M |
| SeaStar Medical Holding | 17.21M |
| Lipocine | 14.96M |